Clinica
Quarterly round-up: Covidien and Bard solid; LabCorp has mixed quarter
26 April 2011
Madeleine Armstrong
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- Quarterly results round-up: “no better, no worse” for Bard, Roche suffers from exchange rates again
- Covidien sees rosy 2012 with strong finish to fiscal 2011
- Quarterly results round-up: Baxter beat guidance, Boston "in line" but CRM still a problem
- Quarterly results round-up: Covidien shows strong start, Recon still weak but other units give boost to Zimmer and Stryker
Other Informa News
EVENTS
